Argentina eases drug import rules, creating new export avenues for India
The new framework dismantles long-standing regulatory barriers for Indian manufacturers, enabling a direct export of Indian medicines, active pharmaceutical ingredients (APIs), and medical equipment to Tucumán and other provinces.
India's drug manufacturers could now supply medicines directly to Argentina’s provincial governments under a revised regulatory framework that eases barriers to pharmaceutical imports. The new rules allow provincial authorities to import medicines directly, paving the way for Indian drugmakers with GMP certifications issued by WHO, PAHO, or PIC/S recognised regulators to export finished medicines, active pharmaceutical ingredients (APIs), and medical equipment to Argentina.
This development could reduce the need for on-site factory inspections by Argentina’s drug regulator, ANMAT, and potentially expand Indian exporters' presence in Latin America.
Brief written by urgent.news from Live Mint's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
